[Pathophysiology, clinical aspects and therapy of heart insufficiency].
D002301:Cardiac Glycosides / Q000627:therapeutic use*; D002395:Catecholamines / Q000097:blood; D004077:Digoxin / Q000633:toxicity; D004232:Diuretics / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004417:Dyspnea / Q000209:etiology; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D011654:Pulmonary Edema / Q000209:etiology; D014665:Vasodilator Agents / Q000627:therapeutic use
D002301:Cardiac Glycosides; D002395:Catecholamines; D004232:Diuretics; D014665:Vasodilator Agents; D004077:Digoxin
Pathophysiologie, Klinik und Therapie der Herzinsuffizienz.